Literature DB >> 108339

Studies on gonococcus infection. XVII. IgA1-cleaving protease in vaginal washings from women with gonorrhea.

M Blake, K K Holmes, J Swanson.   

Abstract

Vaginal washings from women attending a veneral disease clinic were examined for the presence of protease that cleaved IgA subclass 1 (IgA1). In a crude assay, vaginal washings cleaved [125I]IgA1 in 19 of 25 specimens from individuals from whom Neisseria gonorrhoeae were cultivated. Forty-six specimens from 104 women whose cultures were negative for N. gonorrhoeae also cleaved [125I]IgA1. Vaginal washings from six of six women with culture-proven gonorrhea cleaved [125I]IgA1 into low-molecular-weight components identical to those produced by partially purified IgA1-specific protease from gonococci. The hydrolysis of [125I]IgA1 by vaginal washings from women whose cultures were negative for N. gonorrhoeae yielded cleavage products that resembled those of trypsin or alpha-chymotrypsin. These findings indicate that gonococci residing in the female genital tract produce IgA1-specific protease that can be detected in the vaginal washings of infected women.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 108339     DOI: 10.1093/infdis/139.1.89

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Effects of the immunoglobulin A1 protease on Neisseria gonorrhoeae trafficking across polarized T84 epithelial monolayers.

Authors:  S Hopper; B Vasquez; A Merz; S Clary; J S Wilbur; M So
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Cleavage of a recombinant human immunoglobulin A2 (IgA2)-IgA1 hybrid antibody by certain bacterial IgA1 proteases.

Authors:  B W Senior; J I Dunlop; M R Batten; M Kilian; J M Woof
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Vaccines against gonorrhea: current status and future challenges.

Authors:  Ann E Jerse; Margaret C Bash; Michael W Russell
Journal:  Vaccine       Date:  2013-09-06       Impact factor: 3.641

Review 4.  Humoral immune response to gonococcal infections.

Authors:  G F Brooks; C J Lammel
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

5.  Immunoglobulins in nasal secretions of healthy humans: structural integrity of secretory immunoglobulin A1 (IgA1) and occurrence of neutralizing antibodies to IgA1 proteases of nasal bacteria.

Authors:  L Kirkeby; T T Rasmussen; J Reinholdt; M Kilian
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

6.  A proteolytic enzyme secreted by Proteus mirabilis degrades immunoglobulins of the immunoglobulin A1 (IgA1), IgA2, and IgG isotypes.

Authors:  L M Loomes; B W Senior; M A Kerr
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

7.  Persistence of chlamydial antibodies after pelvic inflammatory disease.

Authors:  M Puolakkainen; E Vesterinen; E Purola; P Saikku; J Paavonen
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

8.  Lack of immunoglobulin A1 protease production by Branhamella catarrhalis.

Authors:  D T McLeod; M J Croughan; F Ahmad; R P Brettle; M A Calder
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

9.  Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae.

Authors:  S R Hedges; M S Mayo; L Kallman; J Mestecky; E W Hook; M W Russell
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Prevalence of IgA and IgG antichlamydial antibodies in women in the third trimester of pregnancy.

Authors:  N G Osborne; Y Hecht; J Gorsline; B A Forbes; F Morgenstern; J Winkelman
Journal:  J Natl Med Assoc       Date:  1988-11       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.